# An 8-week Follow-up to Evaluate the Renewal of Corneal Nerves Structure and Function in Patients With Neurotrophic Keratopathy Treated With Recombinant Human Nerve Growth Factor (rhNGF) Eyedrops

> **NCT04293549** · — · COMPLETED · sponsor: **G. d'Annunzio University** · enrollment: 18 (actual)

## Conditions studied

- Neurotrophic Keratopathy

## Interventions

- **DRUG:** Cenegermin, recombinant human Nerve Growth Factor (rhNGF) eyedrops

## Key facts

- **NCT ID:** NCT04293549
- **Lead sponsor:** G. d'Annunzio University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-03-01
- **Primary completion:** 2018-11-30
- **Final completion:** 2018-11-30
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2020-03-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04293549

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04293549, "An 8-week Follow-up to Evaluate the Renewal of Corneal Nerves Structure and Function in Patients With Neurotrophic Keratopathy Treated With Recombinant Human Nerve Growth Factor (rhNGF) Eyedrops". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04293549. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*